Frontiers in Oncology | Breast Cancer

Original Research

Published on 29 May 2023

A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

in Breast Cancer

Esmeralda García-Torralba
Esther Navarro Manzano
Gines Luengo-Gil
Pilar De la Morena Barrio
Asunción Chaves Benito
Miguel Pérez-Ramos
Beatriz Álvarez-Abril
Alejandra Ivars Rubio
Elisa García-Garre
Francisco Ayala de la Peña

Frontiers in Oncology

doi 10.3389/fonc.2023.1182725

2,537 views
1 citation

Original Research

Published on 26 May 2023

Medicago Sativa Defensin1 as a tumor sensitizer for improving chemotherapy: translation from anti-fungal agent to a potential anti-cancer agent

in Breast Cancer

Raghu Pandurangi
Amol Karwa
Uma Shankar Sagaram
Katherine Henzler-Wildman
Dilip Shah

Frontiers in Oncology

doi 10.3389/fonc.2023.1141755

2,890 views
6 citations

Original Research

Published on 25 May 2023

Breast cancer survival and the health system in Brazil: an analysis of public and private healthcare

in Breast Cancer

Adriana de Souza Sérgio Ferreira
Jane Rocha Duarte Cintra
Vívian Assis Fayer
Mário Círio Nogueira
Cassimiro Baesso Júnior
Maria Teresa Bustamante-Teixeira
Alfredo Chaoubah
Arthur Duarte Cintra
Caroline Montes Simão
Maximiliano Ribeiro Guerra

Frontiers in Oncology

doi 10.3389/fonc.2023.927748

3,770 views
5 citations

Original Research

Published on 25 May 2023

The relationship between women’s body mass index and breast cancer outcomes was U-shaped

in Breast Cancer

Wensong Wei
Suosu Wei
Zhen Huang
Qiuhuan Zhang
Fei Liu
Yujie Xie
Jing Wei
Chongde Mo
Ying Zhou
Shengpeng Qin

Frontiers in Oncology

doi 10.3389/fonc.2023.1191093

1,966 views
3 citations

Original Research

Published on 24 May 2023

DNA methylation differences in noncoding regions in ER negative breast tumors between Black and White women

in Breast Cancer

Jianhong Chen
Michael J. Higgins
Qiang Hu
Thaer Khoury
Song Liu
Christine B. Ambrosone
Zhihong Gong

Frontiers in Oncology

doi 10.3389/fonc.2023.1167815

1,890 views
1 citation

Review

Published on 22 May 2023

Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy

in Breast Cancer

Gang Wang
Yao Yao
Huanhuan Huang
Jun Zhou
Chao Ni

Frontiers in Oncology

doi 10.3389/fonc.2023.1131259

4,850 views
3 citations

Original Research

Published on 19 May 2023

Impact of Atypical Hyperplasia at Surgical Margins on breast cancer outcomes in patients treated with neoadjuvant chemotherapy

in Breast Cancer

An Su
Jing Zhang
Jieqiong Liu
Yaping Yang
Zhou He
Haoshi Bao
Heran Deng
Jiannan Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1202689

1,992 views
1 citation

Original Research

Published on 19 May 2023

Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ

in Breast Cancer

David Dabbs
Karuna Mittal
Scott Heineman
Pat Whitworth
Chirag Shah
Jess Savala
Steven C. Shivers
Troy Bremer

Frontiers in Oncology

doi 10.3389/fonc.2023.1069059

6,000 views
5 citations

Original Research

Published on 18 May 2023

The association between CTSZ methylation in peripheral blood and breast cancer in Chinese women

in Breast Cancer

Jinyu Li
Xiajie Zhou
Lixi Li
Longtao Ji
Jiaqi Li
Yunhui Qu
Zhi Wang
Yutong Zhao
Jie Zhang
Feifei Liang

Frontiers in Oncology

doi 10.3389/fonc.2023.1148635

1,783 views
1 citation

Original Research

Published on 18 May 2023

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer

in Breast Cancer

Yuxia Ruan
Qiang Tang
Jianghua Qiao
Jiabin Wang
Huimin Li
Xiayu Yue
Yadong Sun
Peili Wang
Hanzhao Yang
Zhenzhen Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1171496

1,735 views
1 citation

Original Research

Published on 18 May 2023

Construction of the structural equation model of stigma, self-disclosure, social support, and quality of life of breast cancer patients after surgery—a multicenter study

in Breast Cancer

Liuxiu Bu
Xisui Chen
Shaoyan Zheng
Guanhua Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1142728

2,813 views
9 citations

Case Report

Published on 18 May 2023

Case Report: Intraoperative radiotherapy as the new standard of care for breast cancer patients with disabling health conditions or impairments

in Breast Cancer

Michael Omosule
Shiroma De Silva-Minor
Nathan Coombs

Frontiers in Oncology

doi 10.3389/fonc.2023.1156619

1,969 views
2 citations

Original Research

Published on 17 May 2023

Association between ultrasound BI-RADS signs and molecular typing of invasive breast cancer

in Breast Cancer

Qiao-Hong Pan
Zheng-Pin Zhang
Liu-Yi Yan
Ning-Rui Jia
Xin-Yu Ren
Bei-Ke Wu
Yu-Bing Hao
Zhi-Fang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1110796

2,451 views
1 citation

Original Research

Published on 17 May 2023

Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1–2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy

in Breast Cancer

Seung Eun Lee
Sung Gwe Ahn
Jung Hwan Ji
Yoonwon Kook
Ji Soo Jang
Seung Ho Baek
Joon Jeong
Soong June Bae

Frontiers in Oncology

doi 10.3389/fonc.2023.936148

2,786 views
2 citations

Case Report

Published on 17 May 2023

Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation

in Breast Cancer

Olivia A. Sagan
Anna Rothstein
Bhaghyasree Jambunathan
Mersiha Hadziahmetovic
Anita Antoniolli
M. Hammad Rashid

Frontiers in Oncology

doi 10.3389/fonc.2023.1176868

1,902 views
2 citations

Editorial

Published on 16 May 2023

Editorial: Novel signaling pathways and therapy in breast cancer

in Breast Cancer

Eriko Katsuta
Mateusz Opyrchal

Frontiers in Oncology

doi 10.3389/fonc.2023.1215023

1,136 views
1 citation

Navigation group

Articles

A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

Medicago Sativa Defensin1 as a tumor sensitizer for improving chemotherapy: translation from anti-fungal agent to a potential anti-cancer agent

Breast cancer survival and the health system in Brazil: an analysis of public and private healthcare

The relationship between women’s body mass index and breast cancer outcomes was U-shaped

DNA methylation differences in noncoding regions in ER negative breast tumors between Black and White women

Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy

Impact of Atypical Hyperplasia at Surgical Margins on breast cancer outcomes in patients treated with neoadjuvant chemotherapy

Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ

The association between CTSZ methylation in peripheral blood and breast cancer in Chinese women

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer

Construction of the structural equation model of stigma, self-disclosure, social support, and quality of life of breast cancer patients after surgery—a multicenter study

Case Report: Intraoperative radiotherapy as the new standard of care for breast cancer patients with disabling health conditions or impairments

Association between ultrasound BI-RADS signs and molecular typing of invasive breast cancer

Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1–2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy

Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation

Editorial: Novel signaling pathways and therapy in breast cancer